SCHEMBL7981389

SCHEMBL7981389

Nc1ccc2nc(N)c3cnc(-c4c(Cl)cccc4Cl)n3c2c1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.41
SRC P12931 3/20 0.41
LCK P06239 2/20 0.41
TLR7 Q9NYK1 4/20 0.36
PDE2A O00408 3/20 0.35
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983002 0.94 LCK (0.46) FGFR1SRCLCKTLR7PDE2A
SCHEMBL7969762 0.84 LCK (0.46) FGFR1SRCLCKTLR7PDE2A
SCHEMBL7983558 0.80 LCK (0.39) FGFR1SRCLCKTLR7PDE2A
SCHEMBL7984047 0.78 LCK (0.37) FGFR1SRCLCKTLR7PDE2A
SCHEMBL7983062 0.78 LCK (0.50) FGFR1LCKTLR7PDE2A
SCHEMBL7969613 0.75 PDE2A (0.38) LCKPDE2ASMN1; SMN2PDE10A
SCHEMBL7983240 0.75 PDE2A (0.43) FGFR1LCKPDE2AKDM4EPDE10A
SCHEMBL7969906 0.74 LCK (0.37) LCKPDE2A
SCHEMBL7979955 0.74 LCK (0.54) FGFR1LCKPDE2A
SCHEMBL7981250 0.73 PDE2A (0.40) FGFR1SRCLCKTLR7PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed